Acrobiosystems Co.,Ltd. (SHE:301080)
China
· Delayed Price · Currency is CNY 45.49
-0.05 (-0.11%)
At close: Apr 29, 2026
Acrobiosystems Revenue
Acrobiosystems had revenue of 235.59M CNY in the quarter ending March 31, 2026, with 26.33% growth. This brings the company's revenue in the last twelve months to 887.21M, up 29.42% year-over-year. In the year 2025, Acrobiosystems had annual revenue of 838.12M with 29.94% growth.
Revenue (ttm)
887.21M
Revenue Growth
+29.42%
P/S Ratio
9.07
Revenue / Employee
964.46K
Employees
869
Market Cap
7.60B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nanjing Vazyme Biotech | 1.41B |
| Jiangsu Aidea Pharmaceutical Group | 719.17M |
| Chengdu Kanghua Biological Products | 1.20B |
| Daan Gene | 765.48M |
| GemPharmatech | 830.61M |
| Suzhou Fengbei Biotech Stock | 3.17B |
| Zhejiang Ausun Pharmaceutical | 751.12M |
| Anhui Huaheng Biotechnology | 2.95B |